Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Melamed

Showing results (181-190 of 311) with videos related to

Pageof 32
Sort By:
Neuroradiology|January 1, 1984
The assessment of changes in brain volume using combined linear measurements. A CT-scan studyJ M Gomori, I Steiner, E Melamed, et al.
Israel Journal of Medical Sciences|January 1, 1995
Intravenous immunoglobulin treatment in multiple sclerosisA Achiron, I R Cohen, O Lider, et al.
Prostaglandins and Medicine|March 1, 1980
The synthesis of prostaglandins by bovine cerebral microvesselsP Maurer, M A Moskowitz, L Levine, et al.
Journal of Neural Transmission|January 1, 1980
Plasma tyrosine in normal humans: effects of oral tyrosine and protein-containing mealsE Melamed, B Glaeser, J H Growdon, et al.
Neuroscience Letters|August 29, 1986
Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)G Martinovits, E Melamed, O Cohen, et al.
Neuroscience Letters|December 16, 1987
Effect of intrastriatal and intranigral administration of synthetic neuromelanin on the dopaminergic neurotoxicity of MPTP in rodentsE Melamed, D Soffer, J Rosenthal, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|March 22, 2000
Developmental changes in antioxidant enzymes and oxidative damage in kidneys, liver and brain of bcl-2 knockout miceA Hochman, H Liang, D Offen, et al.
Clinical Neuropharmacology|February 1, 1993
Short-term beneficial effect of deprenyl monotherapy in early Parkinson's disease: a quantitative assessmentI Ziv, A Achiron, R Djaldetti, et al.
Advances in Neurology|January 1, 1996
Involvement of serotonin in clinical features of Parkinson's disease and complications of L-DOPA therapyE Melamed, J Zoldan, G Friedberg, et al.
Journal of Neurology|December 5, 1998
Diagnosis of "non-organic" limb paresis by a novel objective motor assessment: the quantitative Hoover's testI Ziv, R Djaldetti, Y Zoldan, et al.
Pageof 32

Showing results (181-190 of 311) with videos related to

Sort By:
Pageof 32
Neuroradiology|January 1, 1984
The assessment of changes in brain volume using combined linear measurements. A CT-scan studyJ M Gomori, I Steiner, E Melamed, et al.
Israel Journal of Medical Sciences|January 1, 1995
Intravenous immunoglobulin treatment in multiple sclerosisA Achiron, I R Cohen, O Lider, et al.
Prostaglandins and Medicine|March 1, 1980
The synthesis of prostaglandins by bovine cerebral microvesselsP Maurer, M A Moskowitz, L Levine, et al.
Journal of Neural Transmission|January 1, 1980
Plasma tyrosine in normal humans: effects of oral tyrosine and protein-containing mealsE Melamed, B Glaeser, J H Growdon, et al.
Neuroscience Letters|August 29, 1986
Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP)G Martinovits, E Melamed, O Cohen, et al.
Neuroscience Letters|December 16, 1987
Effect of intrastriatal and intranigral administration of synthetic neuromelanin on the dopaminergic neurotoxicity of MPTP in rodentsE Melamed, D Soffer, J Rosenthal, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|March 22, 2000
Developmental changes in antioxidant enzymes and oxidative damage in kidneys, liver and brain of bcl-2 knockout miceA Hochman, H Liang, D Offen, et al.
Clinical Neuropharmacology|February 1, 1993
Short-term beneficial effect of deprenyl monotherapy in early Parkinson's disease: a quantitative assessmentI Ziv, A Achiron, R Djaldetti, et al.
Advances in Neurology|January 1, 1996
Involvement of serotonin in clinical features of Parkinson's disease and complications of L-DOPA therapyE Melamed, J Zoldan, G Friedberg, et al.
Journal of Neurology|December 5, 1998
Diagnosis of "non-organic" limb paresis by a novel objective motor assessment: the quantitative Hoover's testI Ziv, R Djaldetti, Y Zoldan, et al.
Pageof 32